Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Type I collagen vaginal gel for female pelvic floor dysfunction
ChiCTR2300070529Phase 4Recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Mar 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of type I collagen vaginal gel in Urogynaecological Disorders, pelvic organ prolapse (POP), stress urinary incontinence (SUI) and 4 more (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoints: MOS item short form health survey (SF-36), Pelvic Floor Distress Inventory-Short Form 20 (PFDI-20) and 3 more. Started Mar 2023; status: recruiting.
02
Drugs
type I collagen vaginal gel
03
Conditions
Urogynaecological Disorderspelvic organ prolapse (POP)stress urinary incontinence (SUI)overactive bladder (OAB)vaginal atrophy
Beyond the preview
Go deeper on ChiCTR2300070529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070529.